Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive breast cancer with limited treatment options. Glycosylation has been implicated in cancer development, but TNBC-specific glycosylation pathways have not been examined. Here, we applied bioinformatic analyses on public datasets to discover TNBC-sp...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3330 |
_version_ | 1797528090053705728 |
---|---|
author | Ruichao Zeng Ahmed Mohamed Kum Kum Khanna Michelle M. Hill |
author_facet | Ruichao Zeng Ahmed Mohamed Kum Kum Khanna Michelle M. Hill |
author_sort | Ruichao Zeng |
collection | DOAJ |
description | Triple-negative breast cancer (TNBC) is an aggressive breast cancer with limited treatment options. Glycosylation has been implicated in cancer development, but TNBC-specific glycosylation pathways have not been examined. Here, we applied bioinformatic analyses on public datasets to discover TNBC-specific glycogenes and pathways, as well as their upstream regulatory mechanisms. Unsupervised clustering of 345 glycogene expressions in breast cancer datasets revealed a relative homogenous expression pattern in basal-like TNBC subtype. Differential expression analyses of the 345 glycogenes between basal-like TNBC (hereafter termed TNBC) and other BC subtypes, or normal controls, revealed 84 differential glycogenes in TNBC. Pathway enrichment showed two common TNBC-enriched pathways across all three datasets, cell cycle and lacto-/neolacto- glycosphingolipid (GSL) biosynthesis, while a total of four glycosylation-related pathways were significantly enriched in TNBC. We applied a selection criterion of the top 50% differential anabolic/catabolic glycogenes in the enriched pathways to define 34 TNBC-specific glycogenes. The lacto-/neolacto- GSL biosynthesis pathway was the most highly enriched, with seven glycogenes all up-regulated in TNBC. This data led us to investigate the hypothesis that a common upstream mechanism in TNBC up-regulates the lacto-/neolacto-GSL biosynthesis pathway. Using public multi-omic datasets, we excluded the involvement of copy-number alteration and DNA methylation, but identified three transcription factors (AR, GATA3 and ZNG622) that each target three candidate genes in the lacto-/neolacto- GSL biosynthesis pathway. Interestingly, a subset of TNBC has been reported to express AR and GATA3, and AR antagonists are being trialed for TNBC. Our findings suggest that AR and GATA3 may contribute to TNBC via GSL regulation, and provide a list of candidate glycogenes for further investigation. |
first_indexed | 2024-03-10T09:53:09Z |
format | Article |
id | doaj.art-bde1f029d7f24f5481561d25ff3619e4 |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-10T09:53:09Z |
publishDate | 2021-07-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-bde1f029d7f24f5481561d25ff3619e42023-11-22T02:36:13ZengMDPI AGCancers2072-66942021-07-011313333010.3390/cancers13133330Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast CancerRuichao Zeng0Ahmed Mohamed1Kum Kum Khanna2Michelle M. Hill3Precision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaPrecision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaSignal Transduction Laboratory, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaPrecision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaTriple-negative breast cancer (TNBC) is an aggressive breast cancer with limited treatment options. Glycosylation has been implicated in cancer development, but TNBC-specific glycosylation pathways have not been examined. Here, we applied bioinformatic analyses on public datasets to discover TNBC-specific glycogenes and pathways, as well as their upstream regulatory mechanisms. Unsupervised clustering of 345 glycogene expressions in breast cancer datasets revealed a relative homogenous expression pattern in basal-like TNBC subtype. Differential expression analyses of the 345 glycogenes between basal-like TNBC (hereafter termed TNBC) and other BC subtypes, or normal controls, revealed 84 differential glycogenes in TNBC. Pathway enrichment showed two common TNBC-enriched pathways across all three datasets, cell cycle and lacto-/neolacto- glycosphingolipid (GSL) biosynthesis, while a total of four glycosylation-related pathways were significantly enriched in TNBC. We applied a selection criterion of the top 50% differential anabolic/catabolic glycogenes in the enriched pathways to define 34 TNBC-specific glycogenes. The lacto-/neolacto- GSL biosynthesis pathway was the most highly enriched, with seven glycogenes all up-regulated in TNBC. This data led us to investigate the hypothesis that a common upstream mechanism in TNBC up-regulates the lacto-/neolacto-GSL biosynthesis pathway. Using public multi-omic datasets, we excluded the involvement of copy-number alteration and DNA methylation, but identified three transcription factors (AR, GATA3 and ZNG622) that each target three candidate genes in the lacto-/neolacto- GSL biosynthesis pathway. Interestingly, a subset of TNBC has been reported to express AR and GATA3, and AR antagonists are being trialed for TNBC. Our findings suggest that AR and GATA3 may contribute to TNBC via GSL regulation, and provide a list of candidate glycogenes for further investigation.https://www.mdpi.com/2072-6694/13/13/3330triple-negative breast cancerglycosylationglycogenesglycosphingolipidslactoneo-lacto |
spellingShingle | Ruichao Zeng Ahmed Mohamed Kum Kum Khanna Michelle M. Hill Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer Cancers triple-negative breast cancer glycosylation glycogenes glycosphingolipids lacto neo-lacto |
title | Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer |
title_full | Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer |
title_fullStr | Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer |
title_full_unstemmed | Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer |
title_short | Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer |
title_sort | differential regulation of lacto neolacto glycosphingolipid biosynthesis pathway reveals transcription factors as potential candidates in triple negative breast cancer |
topic | triple-negative breast cancer glycosylation glycogenes glycosphingolipids lacto neo-lacto |
url | https://www.mdpi.com/2072-6694/13/13/3330 |
work_keys_str_mv | AT ruichaozeng differentialregulationoflactoneolactoglycosphingolipidbiosynthesispathwayrevealstranscriptionfactorsaspotentialcandidatesintriplenegativebreastcancer AT ahmedmohamed differentialregulationoflactoneolactoglycosphingolipidbiosynthesispathwayrevealstranscriptionfactorsaspotentialcandidatesintriplenegativebreastcancer AT kumkumkhanna differentialregulationoflactoneolactoglycosphingolipidbiosynthesispathwayrevealstranscriptionfactorsaspotentialcandidatesintriplenegativebreastcancer AT michellemhill differentialregulationoflactoneolactoglycosphingolipidbiosynthesispathwayrevealstranscriptionfactorsaspotentialcandidatesintriplenegativebreastcancer |